2 results
Approved WMORecruiting
The primary objective of this study is to demonstrate efficacy of BIIB059compared with placebo in participants with active systemic lupuserythematosus (SLE), who are receiving background lupus standard ofcare (SOC) therapy in reducing diseaseā¦
Approved WMOPending
The Primary Objective of this Clinical Trial is to evaluate the long-term safety and tolerability of BIIB059 in participants with active SLE.The Secondary Objectives of this Clinical Trial are:- to evaluate the long-term effect of BIIB059 on diseaseā¦